Dr. Omar Mohammed Moinuddin, MD

Dr. Moinuddin practices at Jawad a Qureshi MD PA in Southlake, Texas.

Dr. Moinuddin's NPI, 1477114296, was assigned on June 24, 2019. Dr. Moinuddin graduated from Oakland Univ, William Beaumont School of Medicine in 2018. Dr. Moinuddin holds Michigan license 4301509019.

Dr. Moinuddin's primary practice is Jawad a Qureshi MD PA, at 305 Morrison Park Dr, Southlake, TX 76092 in Tarrant County. The practice phone is (817) 865-6800.

Dr. Moinuddin's primary practice is Jawad a Qureshi MD PA in Southlake, Texas. Dmand AI also links Dr. Moinuddin to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moinuddin practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Moinuddin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Moinuddin is licensed in Michigan.

CMS data shows 95 Medicare services from Dr. Moinuddin across 4 procedure codes in 2024, for 108 Medicare patients. Medicare paid $9,513 for them.

CMS counts 108 Medicare patients who saw Dr. Moinuddin in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moinuddin's median patient age at 66, with 49% women.

In 2024, Dr. Moinuddin wrote 554 Medicare Part D claims for 235 patients. 62% of them were for generic drugs. CMS names the drug for 470 of them, across 5 drugs with 11 or more claims each, at $13,158 in total drug cost. In 2023, CMS named 370 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Moinuddin for performance year 2024, reported as part of a group. Dr. Moinuddin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Moinuddin, published from 2018 to 2022. 2018 was the busiest year, with 3. The most frequent topics are Fluorescein Angiography, Fundus Oculi and Retina. Dr. Moinuddin has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Moinuddin's most frequent co-authors are Emmanuel Yih-Herng Chang, MD, PhD, Prethy Rao, MD and Thomas Joseph Wubben, MD, PhD.

CMS Open Payments shows 40 general payments to Dr. Moinuddin from 13 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 69% of the total. EyePoint Pharmaceuticals US, Inc. paid the most, $1,205.

Dr. Moinuddin graduated from Oakland Univ, William Beaumont School of Medicine in 2018.